Johnson & Johnson announced its fourth quarter and year-end financials, and its medical device and diagnostic sales increased 3.9 percent from 2012.
Total global 2013 sales totaled $28.5 million, up from 2012's $27.4 million. Fourth quarter device sales, which totaled $7.3 million, dropped 1 percent compared to the same period last year.
Read the full article on Becker's Spine Review.
Total global 2013 sales totaled $28.5 million, up from 2012's $27.4 million. Fourth quarter device sales, which totaled $7.3 million, dropped 1 percent compared to the same period last year.
Read the full article on Becker's Spine Review.